Cadila Healthcare Gains Over 2% After Unit Buys Drug For Menkes Disease

Cadila Healthcare said that its US subsidiary has acquired an experimental drug from Cyprium for treating Menkes disease, which is a rare recessive pediatric disease

 
– NDTV Profit – Latest

• Share on Facebook
• Tweet it
• Pin it
• Share it
• Email